Mednax Inc (MD)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 2,152,700 | 2,219,810 | 2,347,890 | 2,722,550 | 3,347,950 |
| Total stockholders’ equity | US$ in thousands | 764,938 | 849,061 | 891,632 | 896,692 | 747,717 |
| Financial leverage ratio | 2.81 | 2.61 | 2.63 | 3.04 | 4.48 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,152,700K ÷ $764,938K
= 2.81
The financial leverage ratio of Mednax Inc has shown a decreasing trend over the past five years, starting at 4.48 in December 31, 2020, and decreasing to 3.04 in December 31, 2021, 2.63 in December 31, 2022, 2.61 in December 31, 2023, before slightly increasing to 2.81 in December 31, 2024.
This indicates that the company has been reducing its reliance on debt to finance its operations and investments. A lower financial leverage ratio suggests a lower level of financial risk for the company, as it indicates a higher proportion of equity in the capital structure compared to debt.
Overall, the decreasing trend in the financial leverage ratio of Mednax Inc over the years reflects a more conservative approach to financial management, which could lead to greater stability and resilience in the face of economic challenges.
Peer comparison
Dec 31, 2024